Molecular cloning and expression of the rhesus macaque D1 dopamine receptor gene

CA Machida, RP Searles, V Nipper, JA Brown, LB Kozell and KA Neve

Division of Neuroscience, Oregon Regional Primate Research Center, Beaverton 97006.

Using homologous probes for the cloning of related genes within the family of guanine nucleotide-binding protein-coupled receptors, we have cloned the gene for the rhesus macaque D1 dopamine receptor. By using the rat D1 receptor coding sequence as a probe under high stringency conditions, the rhesus D1 receptor gene was isolated from a lambda EMBL3 rhesus genomic DNA library. The rhesus D1 dopamine receptor gene is intronless and encodes a 446-amino acid protein that contains two consensus sites for asparagine-linked glycosylation (Asn-5 and Asn-176) and two consensus sites for cAMP-dependent protein kinase phosphorylation (Thr-136 and Thr-268). The primary amino acid sequence of the rhesus D1 dopamine receptor shows an extremely high degree of similarity (99.6%) to the human D1 receptor. Genomic DNA analyses conducted with high and reduced stringency hybridizations indicate that the rhesus macaque D1 receptor is a member of a large multigene family. Like the human D1 receptor mRNA, the rhesus D1 receptor mRNA is approximately 4 kilobases in size and is localized predominantly in the caudate, with lesser amounts in the hippocampus and cortex. The rhesus D1 receptor coding region was inserted into the cytomegalovirus promoter-driven expression vector pcDNA-1, and the recombinant (pcDNA- D1) was cotransfected with the selectable marker pRSVneo, conferring G418 resistance, into D1 receptor-deficient C6 glioma cells. Analyses of the selected transfectant demonstrate the expression of a high affinity, functional D1 dopamine receptor. The D1 receptor radioligand [3H]SCH 23390 bound transfectant membranes with an affinity (Kd), of 0.3 nM; the D2-selective ligand spiperone, the dopamine receptor ligand clozapine, and the serotonin receptor antagonist ketanserin bound with considerably lower affinities (102, 80, and 95 nM, respectively). Both dopamine and the D1-selective agonist SKF 38393 inhibited the binding of [3H]SCH 23390 to transfectant cell membranes; the binding of these agonists was sensitive to GTP. Dopamine potently stimulated the accumulation of cAMP in transfected C6 cells, whereas SKF 38393 was a partial agonist in these cells. Also, the density of recombinant D1 receptors on the transfectant cells was decreased 40% upon treatment with 10 microM dopamine, indicating that occupation of recombinant D1 receptors by agonists alters surface expression of the receptors.

Volume 41, Issue 4, pp. 652-659, 04/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				H. Lan, C. J. DuRand, M. M. Teeter, and K. A. Neve Structural Determinants of Pharmacological Specificity Between D1 and D2 Dopamine Receptors Mol. Pharmacol., January 1, 2006; 69(1): 185 - 194. [Abstract] [Full Text] [PDF]

				J. P. Ryman-Rasmussen, D. E. Nichols, and R. B. Mailman Differential Activation of Adenylate Cyclase and Receptor Internalization by Novel Dopamine D1 Receptor Agonists Mol. Pharmacol., October 1, 2005; 68(4): 1039 - 1048. [Abstract] [Full Text] [PDF]

				J. N. Mason, L. B. Kozell, and K. A. Neve Regulation of Dopamine D1 Receptor Trafficking by Protein Kinase A-Dependent Phosphorylation Mol. Pharmacol., April 1, 2002; 61(4): 806 - 816. [Abstract] [Full Text] [PDF]

				A. Mayerhofer, S. Fritz, R. Grünert, S. L. Sanders, D. M. Duffy, S. R. Ojeda, and R. L. Stouffer D1-Receptor, DARPP-32, and PP-1 in the Primate Corpus Luteum and Luteinized Granulosa Cells: Evidence for Phosphorylation of DARPP-32 by Dopamine and Human Chorionic Gonadotropin J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4750 - 4757. [Abstract] [Full Text]

				A. Lavin and A. A. Grace Dopamine Modulates the Responsivity of Mediodorsal Thalamic Cells Recorded In Vitro J. Neurosci., December 15, 1998; 18(24): 10566 - 10578. [Abstract] [Full Text] [PDF]

				M. M. Lewis, V. J. Watts, C. P. Lawler, D. E. Nichols, and R. B. Mailman Homologous Desensitization of the D1A Dopamine Receptor: Efficacy in Causing Desensitization Dissociates from Both Receptor Occupancy and Functional Potency J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 345 - 353. [Abstract] [Full Text]

				L. L. Demchyshyn, K. S. Sugamori, F. J. S. Lee, S. A. Hamadanizadeh, and H. B. Niznik The Dopamine D1D Receptor J. Biol. Chem., February 24, 1995; 270(8): 4005 - 4012. [Abstract] [Full Text] [PDF]